The Centers for Medicare & Medicaid Services (CMS) issued proposed rules to update the End-Stage Renal Disease (ESRD) prospective payment rates and quality incentive program (QIP) and ambulance fee schedules, as well as proposed changes to the definition of Durable Medical Equipment (DME). CMS projects payment rates for dialysis treatments will increase by 1.8 percent, representing a projected inflation (or ESRD market basket) increase of 3 percent, less a projected productivity adjustment of 1.2 percent as required by statute, effective for dialysis treatments furnished for calendar year 2012.